Eargo, Inc. Common Stock
EAR was delisted on the 15th of February, 2024.
0 hedge funds and large institutions have $0 invested in Eargo, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 23 closing their positions.
100% less funds holding
Funds holding: 23 → 0 (-23)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $44.2M → $0 (-$44.2M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 23
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PSC
Patient Square Capital
Menlo Park,
California
|
-$41M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.28M |
| 3 |
BlackRock
New York
|
-$627K |
| 4 |
NFGH
Nan Fung Group Holdings
Kai Tak,
Hong Kong
|
-$383K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$223K |
EAR Hedge Fund Activity: Q1 2024 in Review
0 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Eargo, Inc. Common Stock (EAR) for Q1 2024, worth a combined $0 — down 100% from $44.2M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of EAR and 0 opened new positions — a net loss of 23 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Patient Square Capital, exiting entirely with an estimated $41M sold.
- 0 institutional investors held Eargo, Inc. Common Stock (EAR) as of Q1 2024, down from 23 in Q4 2023.
- Funds reported $0 of Eargo, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
- 0 funds opened new Eargo, Inc. Common Stock positions in Q1 2024 and 23 closed out, a net change of -23 holders.
- The largest Eargo, Inc. Common Stock seller in Q1 2024 was Patient Square Capital, an estimated $41M sold.
Based on aggregated 13F filings for Q1 2024.